Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 14

1.

Plectasin, a fungal defensin, targets the bacterial cell wall precursor Lipid II.

Schneider T, Kruse T, Wimmer R, Wiedemann I, Sass V, Pag U, Jansen A, Nielsen AK, Mygind PH, Raventós DS, Neve S, Ravn B, Bonvin AM, De Maria L, Andersen AS, Gammelgaard LK, Sahl HG, Kristensen HH.

Science. 2010 May 28;328(5982):1168-72. doi: 10.1126/science.1185723.

2.

Antimicrobial peptides effectively kill a broad spectrum of Listeria monocytogenes and Staphylococcus aureus strains independently of origin, sub-type, or virulence factor expression.

Gottlieb CT, Thomsen LE, Ingmer H, Mygind PH, Kristensen HH, Gram L.

BMC Microbiol. 2008 Nov 26;8:205. doi: 10.1186/1471-2180-8-205.

3.

Antimicrobial activity of the recombinant designer host defence peptide P-novispirin G10 in infected full-thickness wounds of porcine skin.

Jacobsen F, Mohammadi-Tabrisi A, Hirsch T, Mittler D, Mygind PH, Sonksen CP, Raventos D, Kristensen HH, Gatermann S, Lehnhardt M, Daigeler A, Steinau HU, Steinstraesser L.

J Antimicrob Chemother. 2007 Mar;59(3):493-8. Epub 2007 Feb 8.

PMID:
17289767
4.

Design of novispirin antimicrobial peptides by quantitative structure-activity relationship.

Taboureau O, Olsen OH, Nielsen JD, Raventos D, Mygind PH, Kristensen HH.

Chem Biol Drug Des. 2006 Jul;68(1):48-57.

PMID:
16923026
5.

Plectasin is a peptide antibiotic with therapeutic potential from a saprophytic fungus.

Mygind PH, Fischer RL, Schnorr KM, Hansen MT, Sönksen CP, Ludvigsen S, Raventós D, Buskov S, Christensen B, De Maria L, Taboureau O, Yaver D, Elvig-Jørgensen SG, Sørensen MV, Christensen BE, Kjaerulff S, Frimodt-Moller N, Lehrer RI, Zasloff M, Kristensen HH.

Nature. 2005 Oct 13;437(7061):975-80.

PMID:
16222292
6.

Effects of intratracheal administration of novispirin G10 on a rat model of mucoid Pseudomonas aeruginosa lung infection.

Song Z, Wu H, Mygind P, Raventos D, Sonksen C, Kristensen HH, Høiby N.

Antimicrob Agents Chemother. 2005 Sep;49(9):3868-74.

7.

Improving on nature's defenses: optimization & high throughput screening of antimicrobial peptides.

Raventós D, Taboureau O, Mygind PH, Nielsen JD, Sonksen CP, Kristensen HH.

Comb Chem High Throughput Screen. 2005 May;8(3):219-33. Review.

PMID:
15892624
8.

Membrane proteins PmpG and PmpH are major constituents of Chlamydia trachomatis L2 outer membrane complex.

Mygind PH, Christiansen G, Roepstorff P, Birkelund S.

FEMS Microbiol Lett. 2000 May 15;186(2):163-9.

9.

Detection of Chlamydia trachomatis-specific antibodies in human sera by recombinant major outer-membrane protein polyantigens.

Mygind P, Christiansen G, Persson K, Birkelund S.

J Med Microbiol. 2000 May;49(5):457-65.

PMID:
10798559
10.

Molecular biology of Chlamydia pneumoniae surface proteins and their role in immunopathogenicity.

Christiansen G, Boesen T, Hjerno K, Daugaard L, Mygind P, Madsen AS, Knudsen K, Falk E, Birkelund S.

Am Heart J. 1999 Nov;138(5 Pt 2):S491-5.

PMID:
10539856
11.

Identification of two novel genes encoding 97- to 99-kilodalton outer membrane proteins of Chlamydia pneumoniae.

Knudsen K, Madsen AS, Mygind P, Christiansen G, Birkelund S.

Infect Immun. 1999 Jan;67(1):375-83.

12.

Topological analysis of Chlamydia trachomatis L2 outer membrane protein 2.

Mygind P, Christiansen G, Birkelund S.

J Bacteriol. 1998 Nov;180(21):5784-7.

13.

Analysis of the humoral immune response to Chlamydia outer membrane protein 2.

Mygind P, Christiansen G, Persson K, Birkelund S.

Clin Diagn Lab Immunol. 1998 May;5(3):313-8.

14.

Characterization of two conformational epitopes of the Chlamydia trachomatis serovar L2 DnaK immunogen.

Birkelund S, Mygind P, Holm A, Larsen B, Beck F, Christiansen G.

Infect Immun. 1996 Mar;64(3):810-7.

Supplemental Content

Loading ...
Support Center